13D/13G Filings - Cormorant Asset Management, LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, 7, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-12-27
4:15 pm
Purchase
2022-12-1413GAvidity Biosciences, Inc.
RNA
Cormorant Asset Management, LP2,762,115
5.070%
750,000increase
(+37.27%)
Filing
History
2022-12-21
4:32 pm
Purchase
2022-12-1313DErasca, Inc.
ERAS
Cormorant Asset Management, LP10,893,107
7.260%
387,554increase
(+3.69%)
Filing
History
2022-10-31
4:01 pm
Purchase
2022-10-2013GCabaletta Bio, Inc.
CABA
Cormorant Asset Management, LP2,000,000
7.810%
845,576increase
(+73.25%)
Filing
History
2022-09-02
4:10 pm
Purchase
2022-08-2313GAstria Therapeutics, Inc.
ATXS
Cormorant Asset Management, LP1,200,000
5.380%
1,200,000increase
(New Position)
Filing
History
2022-08-29
4:00 pm
Purchase
2022-08-1813GArcellx, Inc.
ACLX
Cormorant Asset Management, LP2,200,000
5.020%
2,200,000increase
(New Position)
Filing
History
2022-07-07
4:01 pm
Purchase
2022-06-2713GAltimmune, Inc.
ALT
Cormorant Asset Management, LP3,000,000
6.130%
3,000,000increase
(New Position)
Filing
History
2022-06-17
4:30 pm
Purchase
2021-12-3113GVectivBio Holding AG
VECT
Cormorant Asset Management, LP2,840,389
6.160%
2,840,389increase
(New Position)
Filing
History
2022-06-06
5:50 pm
Purchase
2022-06-0313GPrometheus Biosciences, Inc.
RXDX
Cormorant Asset Management, LP2,224,847
5.680%
376,825increase
(+20.39%)
Filing
2022-02-14
3:18 pm
Purchase
2022-02-0213GGreenLight Biosciences Holdings
GRNA
Cormorant Asset Management, LP9,479,058
7.720%
9,479,058increase
(New Position)
Filing
History
2022-02-14
3:17 pm
Purchase
2021-12-3113GTango Therapeutics, Inc.
TNGX
Cormorant Asset Management, LP4,899,184
5.600%
4,899,184increase
(New Position)
Filing
History
2022-02-14
3:16 pm
Purchase
2021-12-3113GLongboard Pharmaceuticals, Inc.
LBPH
Cormorant Asset Management, LP1,381,932
9.990%
42,301increase
(+3.16%)
Filing
History
2022-02-14
3:15 pm
Sale
2021-12-3113GPrometheus Biosciences, Inc.
RXDX
Cormorant Asset Management, LP1,848,022
4.750%
-250,000decrease
(-11.92%)
Filing
2022-02-14
3:14 pm
Sale
2021-12-3113GGalecto, Inc.
GLTO
Cormorant Asset Management, LP40,810
4.040%
-45,220decrease
(-52.56%)
Filing
History
2022-02-14
3:13 pm
Purchase
2021-12-3113GForma Therapeutics Holdings, Inc.
FMTX
Cormorant Asset Management, LP4,639,998
9.790%
179,998increase
(+4.04%)
Filing
History
2022-02-14
3:12 pm
Sale
2021-12-3113GCabaletta Bio, Inc.
CABA
Cormorant Asset Management, LP1,154,424
4.070%
-750,000decrease
(-39.38%)
Filing
History
2022-02-14
3:11 pm
Sale
2021-12-3113GC4 Therapeutics, Inc.
CCCC
Cormorant Asset Management, LP0
0.000%
-2,490,065decrease
(Position Closed)
Filing
History
2022-02-14
3:10 pm
Sale
2021-12-3113GAerovate Therapeutics, Inc.
AVTE
Cormorant Asset Management, LP52,305
7.500%
-5,714decrease
(-9.85%)
Filing
History
2022-02-14
3:10 pm
Sale
2021-12-3113GRevolution Medicines, Inc.
RVMD
Cormorant Asset Management, LP2,431,852
3.300%
-1,243,148decrease
(-33.83%)
Filing
History
2022-02-14
3:09 pm
Sale
2021-12-3113GAmbrx Biopharma Inc.
AMAM
Cormorant Asset Management, LP17,266,144
7.060%
-138,558decrease
(-0.80%)
Filing
History
2022-02-14
3:08 pm
Sale
2021-12-3113GMonte Rosa Therapeutics, Inc.
GLUE
Cormorant Asset Management, LP3,002,200
6.460%
-191,774decrease
(-6.00%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, 7, Next